Definition of Congenital Cytomegalovirus (CMV)

Cytomegalovirus (CMV) is a virus that belongs to a family called herpesviruses or herpesvirus-5 (HHV-5). Its symptomatology can range from no symptoms to severe organ dysfunction, particularly in immunocompromised patients or those diagnosed with congenital CMV disease.¹ 

Importance of understanding CMV risks in congenital cases 

It is crucial to understand the high risk that a congenital CMV infection poses. This type of infection has been defined as the most common non-genetic cause of hearing loss and neurological disorders in children.² The impact of congenital CMV extends beyond immediate health concerns, as it can lead to long-term developmental issues, including cognitive deficits and motor impairments.³ Moreover, research indicates that congenital CMV may be linked to other conditions, including sensorineural hearing loss and vision impairment.⁴ Recognizing the diverse manifestations of congenital CMV is essential for early diagnosis and intervention to mitigate the long-term consequences on a child's health and well-being.

Understanding congenital cytomegalovirus (CMV) 

Definition and characteristics

Congenital Cytomegalovirus (CMV) refers to the transmission of the cytomegalovirus to a fetus during pregnancy, leading to potential health complications. CMV is a member of the herpesvirus family and is known for its widespread prevalence, with the majority of infections being asymptomatic in healthy individuals.¹ However, when transmitted congenitally, the virus can result in severe developmental issues, including hearing loss, intellectual disabilities, and vision impairment.⁵

Epidemiology

Epidemiologically, cytomegalovirus (CMV) is a prevalent viral infection affecting individuals of all ages worldwide. Its prevalence varies significantly among populations, with higher rates observed in developing nations and socioeconomically disadvantaged communities. A comprehensive study has emphasized that despite CMV being a widespread global infection, there are substantial variations in seroepidemiology both between and within countries. The acquisition of CMV within a population is characterized by an age-dependent increase in seroprevalence, closely associated with socioeconomic status and racial factors.⁶ The likelihood of congenital transmission substantially increases when primary maternal infection takes place during pregnancy, contrasting with reported cases of CMV transmission resulting from non-primary infection, which account for 1.4% (with a confidence interval of 1.1–1.7%) of instances.⁷ A thorough understanding of CMV's epidemiology is imperative to formulate preventive strategies and effectively manage the associated health risks.

Transmission and risk factors 

Modes of transmission 

Vertical transmission

• In utero transmission: Congenital CMV can be transmitted from mother to fetus during pregnancy, posing a risk of intrauterine infection. This transmission may occur through infected maternal blood, placental tissues, or other bodily fluids³
• Perinatal transmission: CMV can be transmitted during childbirth, exposing the infant to the virus through contact with infected maternal secretions such as saliva, urine, and vaginal fluids⁶

Horizontal transmission

• Transmission in childcare settings: Infants and young children in childcare settings are at an increased risk of CMV transmission due to close contact with others, facilitating the exchange of infected bodily fluids. This can occur through activities like diaper changes, shared toys, and close personal contact⁸
• Risks in healthcare settings: Hospitalized new-borns are susceptible to CMV transmission, particularly through contact with infected healthcare workers or contaminated medical equipments. Implementing strict infection control measures is crucial to mitigate this risk⁹

Understanding the modes of transmission is essential for implementing preventative measures and minimizing the impact of congenital CMV in new-borns. The prevention strategies may include promoting hygiene practices, educating pregnant women on potential risks, and implementing infection control protocols in healthcare and childcare settings.

Risk factors for congenital CMV 

Maternal Factors

• Primary vs. recurrent maternal infection: The risk of congenital CMV transmission is higher during primary maternal infection compared to recurrent infection, resulting in more severe outcomes¹⁰
• Maternal age and parity: Older maternal age and higher parity have been associated with an increased risk of congenital CMV transmission, possibly due to a higher likelihood of exposure to the virus through childcare responsibilities or contact with young children¹¹
• Immune status of the mother: Women with compromised immune systems may have an elevated risk of transmitting CMV to the fetus¹¹

Foetal factors

• Timing of maternal infection: Infections occurring during early pregnancy, particularly in the first trimester, are more likely to result in severe outcomes for the fetus¹²

Other risk factors 

• Socioeconomic factors: Lower socioeconomic status has been linked to an increased risk of congenital CMV, possibly due to limited access to healthcare resources and hygiene practices⁴
• Hygiene practices: Poor hygiene, including inadequate handwashing and close contact with infected bodily fluids, can contribute to CMV transmission¹⁰
• Presence of young children in the household: Having young children in the household may increase the risk of CMV exposure, as they can shed the virus in bodily fluids, leading to congenital transmission¹⁰

Understanding these diverse risk factors is essential for developing targeted preventive measures to reduce the incidence of congenital CMV.

Clinical manifestations and diagnostics

Clinical manifestations of congenital cmv

Symptomatic vs. Asymptomatic Infections

Congenital CMV infections can be categorized into symptomatic and asymptomatic cases. While some infants may display no apparent symptoms at birth (asymptomatic), others may present with clinical manifestations, including neurological deficits, hearing loss, and developmental delays (symptomatic).⁹

Clinical features

Symptomatic congenital CMV infections may include a spectrum of manifestations such as hepatosplenomegaly, thrombocytopenia, jaundice, microcephaly, and intrauterine growth restriction. These clinical features highlight the potential systemic impact of congenital CMV on the developing fetus.³

Diagnostic methods

Prenatal diagnostics

• Ultrasound findings: Prenatal ultrasound examinations can detect certain anomalies associated with congenital CMV, including intracranial calcifications, ventriculomegaly, and echogenic bowel. However, these findings are non-specific and may not confirm CMV infection definitively ¹³
• Amniocentesis and PCR testing: Amniocentesis, combined with polymerase chain reaction (PCR) testing on amniotic fluid, is a more reliable method for diagnosing congenital CMV during pregnancy. This approach allows for the direct detection of viral DNA in the amniotic fluid, providing a more accurate assessment of fetal infection¹⁴

Postnatal diagnostics

Laboratory tests

• Viral culture: Culturing CMV from clinical specimens, such as urine or saliva, can confirm the presence of the virus. However, this method may lack sensitivity, especially in cases of asymptomatic infections¹⁵
• Polymerase chain reaction (PCR): PCR is a highly sensitive and specific diagnostic tool for detecting CMV DNA in various clinical samples, offering an efficient method for confirming congenital CMV infections in both symptomatic and asymptomatic cases¹⁰

Imaging studies

• Magnetic resonance imaging (MRI): Brain imaging using MRI can reveal abnormalities associated with congenital CMV, including ventriculomegaly and periventricular calcifications. MRI plays a crucial role in assessing the extent of neurological involvement in infected infants¹⁶

Prevention, management, and vaccines

Prevention and management

Antenatal interventions

• Education and awareness: Promoting awareness about cytomegalovirus (CMV) among pregnant women is crucial. Educating them on hygiene practices, such as handwashing, and avoiding contact with bodily fluids from young children, helps reduce the risk of CMV transmission during pregnancy¹³
• Screening and testing: Implementing routine screening and testing for CMV during pregnancy allows for early identification of maternal infections. This facilitates timely interventions to mitigate the risk of congenital CMV transmission¹⁴

Postnatal interventions

• Antiviral medications: Antiviral medications, such as ganciclovir and valganciclovir, have shown efficacy in managing symptomatic congenital CMV infections. Early initiation of antiviral treatment may improve outcomes and reduce the severity of long-term complications⁹
• Supportive care and interventions for associated complications: Providing supportive care, including hearing evaluations and early intervention services, is essential for infants with congenital CMV. Addressing associated complications promptly can enhance developmental outcomes and improve the overall quality of life¹⁷

Vaccines and future perspectives

Overview of CMV vaccine development: Ongoing research aims to develop an effective cytomegalovirus vaccine. Several vaccine candidates are in various stages of clinical trials, aiming to induce immune responses that can prevent primary infection or reactivation in individuals at risk, including pregnant women.⁴ Potential impact on reducing congenital CMV risks: A successful CMV vaccine holds the potential to significantly reduce the risk of congenital CMV transmission. By preventing primary maternal infections or decreasing viral shedding, vaccines could contribute to a substantial decline in the incidence of congenital CMV and associated complications.¹⁸

Psychological and social implications 

Impact on families

Congenital cytomegalovirus (CMV) infections can have profound psychological and social implications for affected families. Parents may experience heightened stress and anxiety due to uncertainties about their child's health, potential developmental challenges, and long-term outcomes.²⁰

Support systems

Establishing robust support systems is crucial for families coping with congenital CMV. Access to healthcare professionals, early intervention services, and support groups can provide essential resources and guidance. These support systems not only assist in managing the child's health but also offer emotional support and a sense of community for families facing similar challenges.²¹

Summary

Congenital Cytomegalovirus (CMV) poses significant risks, ranging from asymptomatic infections to severe developmental issues in children. Understanding its diverse mode of transmission , including in utero and perinatal routes, is vital for preventive measures. Factors such as maternal immune status and hygiene practices influence the risk, necessitating targeted interventions. Diagnosis involves prenatal methods like ultrasound and amniocentesis, as well as postnatal techniques like PCR and MRI. Management includes antiviral medications and supportive care, while ongoing vaccine development holds promise for reducing the risks associated with congenital CMV. The psychological impact on families highlights the importance and need of robust support systems for affected individuals.